UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy

Frontiers in immunology, 2021-05, Vol.12, p.669474-669474

2021

Volltextzugriff (PDF)

Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond

NPJ breast cancer, 2020-03, Vol.6 (1), p.10, Article 10

2020

Volltextzugriff (PDF)

Immunotherapy in breast cancer: Current status and future directions

Advances in cancer research, 2019, Vol.143, p.295-349

2019

Volltextzugriff (PDF)

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival

Breast cancer research : BCR, 2017-06, Vol.19 (1), p.75-75, Article 75

2017

Volltextzugriff (PDF)

HER‐2 pulsed dendritic cell vaccine can eliminate HER‐2 expression and impact ductal carcinoma in situ

Cancer, 2012-09, Vol.118 (17), p.4354-4362

2012

Volltextzugriff (PDF)

Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib

PloS one, 2019-01, Vol.14 (1), p.e0210209-e0210209

2019

Volltextzugriff (PDF)

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases

BMC cancer, 2021-03, Vol.21 (1), p.223-8, Article 223

2021

Volltextzugriff (PDF)

CD4+ Th1 to the rescue in HER-2+ breast cancer

Oncoimmunology, 2019-10, Vol.8 (10), p.e1078062-e1078062

2019

Volltextzugriff (PDF)

Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response

Frontiers in immunology, 2019-08, Vol.10, p.1939-1939

2019

Volltextzugriff (PDF)

Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination

Frontiers in immunology, 2021-11, Vol.12, p.786286-786286

2021

Volltextzugriff (PDF)

Differential Production of IL-23 and IL-12 by Myeloid-Derived Dendritic Cells in Response to TLR Agonists

The Journal of immunology (1950), 2008-10, Vol.181 (7), p.5120-5127

2008

Volltextzugriff (PDF)

HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer

Cancer epidemiology, biomarkers & prevention, 2009-05, Vol.18 (5), p.1386-1389

2009

Volltextzugriff (PDF)

Differentiation and Regulation of T H Cells: A Balancing Act for Cancer Immunotherapy

Frontiers in immunology, 2021-05, Vol.12, p.669474

2021

Volltextzugriff (PDF)

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer

Frontiers in immunology, 2023-09, Vol.14, p.1188831-1188831

2023

Volltextzugriff (PDF)

Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography

Journal of biomedical optics, 2009, Vol.14 (2), p.024020-024020

2009

Volltextzugriff (PDF)

Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas

Journal of clinical oncology, 2007-03, Vol.25 (9), p.1129-1134

2007

Volltextzugriff (PDF)

Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer

Annals of surgical oncology, 2017-10, Vol.24 (10), p.2999-3003

2017

Volltextzugriff (PDF)

Optically measured microvascular blood flow contrast of malignant breast tumors

PloS one, 2014-06, Vol.9 (6), p.e99683-e99683

2014

Volltextzugriff (PDF)

Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy

Frontiers in immunology, 2015-06, Vol.6, p.271-271

2015

Volltextzugriff (PDF)

Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses

PloS one, 2011-12, Vol.6 (12), p.e28732-e28732

2011

Volltextzugriff (PDF)

Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention

Frontiers in pharmacology, 2016-10, Vol.7, p.356-356

2016

Volltextzugriff (PDF)

Long-Term CD4+ T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study

Vaccines (Basel), 2022-11, Vol.10 (11), p.1931

2022

Volltextzugriff (PDF)

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases

BMC cancer, 2021-05, Vol.21 (1), p.552-552, Article 552

2021

Volltextzugriff (PDF)

Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field

Journal of clinical oncology, 2009-01, Vol.27 (2), p.279-288

2009

Volltextzugriff (PDF)

Outcomes After Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients: A Systematic Literature Review

Annals of surgical oncology, 2016-10, Vol.23 (10), p.3247-3258

2016

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(255)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Englisch
(273)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy

Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond

Immunotherapy in breast cancer: Current status and future directions

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival

HER‐2 pulsed dendritic cell vaccine can eliminate HER‐2 expression and impact ductal carcinoma in situ

Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases

CD4+ Th1 to the rescue in HER-2+ breast cancer

Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response

Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination

Differential Production of IL-23 and IL-12 by Myeloid-Derived Dendritic Cells in Response to TLR Agonists

HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer

Differentiation and Regulation of T H Cells: A Balancing Act for Cancer Immunotherapy

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer

Differentiation of benign and malignant breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography

Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas

Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer

Optically measured microvascular blood flow contrast of malignant breast tumors

Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy

Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses

Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention

Long-Term CD4+ T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases

Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field

Outcomes After Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients: A Systematic Literature Review

Suchergebnisse filtern